How are pregnant women vulnera blere search participants?

International Journal of Feminist Approaches to Bioethics

Volumn 5, Issue 2, 2012, Pages 82-104

  Wild, Verina ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84875033151     PISSN: 19374585     EISSN: 19374577     Source Type: Journal    
DOI: 10.3138/ijfab.5.2.82     Document Type: Review

References (54)

1. Anderson, Christopher. 1994. Panel backs pregnant women in trials. Science 263 (5151): 1216.
2. Beauchamp, Tom L., and James F. Childress. 2009. Principles of biomedical ethics. New York: Oxford University Press.
3. Biller-Andorno, Nikola, and Verina Wild. 2003a. Arzneimittelforschung an Schwangeren: Besonderer Schutz - aber kein Ausschluss aus der Forschung. Deutsches Ärzteblatt 100 (15): A-970/B-814/C-760.
4. - 2003b. Zwischen Protektion und Protektionismus - medizinethische Überlegungen zur Teilnahme schwangerer Frauen an klinischen Studien. In Das Kind als Patient, ed. Claudia Wiesemann, Andrea Dörries, Gabriele Wolfslast, and Alfred Simon, 302-20. Frankfurt am Main: Campus Verlag.
5. Bobbert, Monika. 2004. Frauenheilkunde und Geburtshilfe. In Gutachten "Probandenund Patientenschutz in der medizinischen Forschung," ed. Monika Bobbert, Uwe
6. B. Brückner, and Hans Lilie, 55-69. Erstellt im Auftrag der Enquête-Kommission "Ethik und Recht der modernen Medizin" des Deutschen Bundestages. http://webarchiv.bundestag.de/archive/2005/0718/ parlament/kommissionen/ethik-med/gutachten/gutachten-03-probandenschutz.pdf (accessed 31 May 2011).
7. Caschetta, Mary Beth, Wendy Chavkin, and Theresa McGovern. 1993. FDA policy onwomen in drug trials. The New England Journal of Medicine 329 (24): 1815-16. (Pubitemid 23355560)
8. Che Yaakob, Che Anuar, Abdulla Abu Dzarr, Ahmad Amir Ismail, Nik Ahmad Zuky Nik Lah, and Jacqueline J. Ho. 2010. Anticoagulant therapy for deep vein thrombosis (DVT) in pregnancy. Cochrane Database of Systematic Reviews 2010 (6): CD007801.
9. Coleman, Carl H. 2009. Vulnerability as a regulatory category in human subject research. Journal of Law, Medicine and Ethics 37 (1): 12-18.
10. Council for International Organizations of Medical Sciences (CIOMS). 2002. International ethical guidelines for biomedical research involving human subjects. www.cioms.ch/publications/layout-guide2002.pdf (accessed 31 May 2011).
11. Council of Europe. 2005. Additional Protocol to the Convention on Human Rights and Biomedicine, concerning Biomedical Research. CETS No.: 195. http://conventions.coe.int/Treaty/en/Treaties/html/195.htm (accessed 31 May 2011).
12. Department of Health and Human Services (HHS). 2009. Code of Federal Regulations. Title 45, Part 46. See Subpart 46.111 (vulnerability) and Subpart 46.204 (research on pregnant women). http://www.hhs.gov/ohrp/humansubjects/ guidance/45cfr46.html#46.204 (accessed 31 May 2011).
13. Dorantes, Dianna M., Alan R. Tait, and Norah N. Naughton. 2000. Informed consent for obstetric anesthesia research: Factors that influence parturients' decisions to participate. Anesthesia and Analgesia 91 (2): 369-73.
14. Duden, Barbara. 1994. Der Frauenleib als öffentlicher Ort. Vom Missbrauch des Begriffs Leben. Munich: Mabuse-Verlag.
15. Faden, Ruth, Anne Drapkin Lyerly, and Maggie Little. 2009. A custom drug. New York Times. http://www.nytimes.com/2009/05/10/opinion/10faden.html (accessed 31 May2011).
16. Food and Drug Administration (FDA). 1977. General considerations for the clinical evaluation of drugs. Publication no. HEW (FDA) 77-3040. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/ Guidances/ucm071682.pdf (accessed 31 May 2011).
17. Goodin, Robert E. 1985. Protecting the vulnerable: A reanalysis of our social responsibilities. Chicago: The University of Chicago Press.
18. Haire, Doris. 2001. FDA approved obstetrics drugs: Their effects on mother and baby. http://nwhalliance.org/FDAAPPROVED.htm (accessed 31 May 2011).
19. Helsinki Declaration. 2008. WMA Declaration of Helsinki - Ethical Principles for Medical Research Involving Human Subjects. http://www.wma.net/en/ 30publications/10policies/b3/ (accessed 31 May 2011).
20. Hurst, Samia A. 2008. Vulnerability in research and health care; Describing the elephant in the room? Bioethics 22 (4): 191-202.
21. Imhof, Christiane. 2005. Antibiotika-Therapie in der Schwangerschaft: Teratogene Risiken von Makroliden, Doxycyclin und Cotrimoxazol. Dissertation zur Erlangung des Doktorgrades der Medizin. Universität Ulm. http://vts.uni-ulm.de/doc.asp?id=5696 (accessed 31 May 2011).
22. Kipnis, Kenneth. 2006. Vulnerability in research subjects: A bioethical taxonomy (research involving human participants V2). Online Ethics Center for Engineering,National Academy of Engineering. www.onlineethics.org/CMS/research/ resref/nbacindex/nbachindex/hkipnis.aspx (accessed 31 May 2011).
23. Langemak, Shari. 2009. Schwangere Frauen im Impf-Dilemma. In Welt Online Wissen. http://www.welt.de/wissenschaft/article4308619/Schwangere-Frauen-im- Impf-Dilemma.html (accessed 31 May 2011).
24. Lenz, Wolfgang, Rudolf A. Pfeiffer, Wilhelm Kosenow, and D. J. Hayman. 1962. Thalidomide and congenital abnormalities. Letter to the editor. The Lancet 279 (7219): 45-6.
25. Levine, Carol, Ruth Faden, Christine Grady, Dale E. Hammerschmidt, Lisa Eckenwiler, and Jeremy Sugarman. 2004. The limitations of " vulnerability" as a protection for human research participants. Consortium to examine clinical research ethics.American Journal of Bioethics 4 (3): 44-49. (Pubitemid 41706523)
26. Little, Margaret Olivia, Anne Drapkin Lyerly, and Ruth R. Faden. 2009. Pregnant women & medical research: A moral imperative. Bioethica Forum 2 (2): 60-65.
27. Luna, Florencia. 2009. Elucidating the concept of vulnerability: Layers not labels. International Journal of Feminist Approaches to Bioethics 2 (1): 121-39.
28. Lyerly, Anne Drapkin, Maggie Little, and Ruth Faden. 2008. The second wave: Toward responsible inclusion of pregnant women in research. International Journal of Feminist Approaches to Bioethics 1 (2): 5-22.
29. Lyerly, Anne Drapkin, Maggie Little, and Ruth Faden. 2009. Pregnancy is no time to refuse a f lu shot. New York Times, September 28. http://www.nytimes.com/2009/09/29/health/views/29essa.html (accessed 31 May 2011).
30. Mackenzie, Catriona. 1992. Abortion and embodiment. Australasian Journal of Philosophy 70 (2): 136-55.
31. Macklin, Ruth. 1994. Reversing the presumption: The IOM report on women in health research. Journal of the American Medical Women's Association 49 (4): 13-16, 21.
32. Marquardt, Ernst. 1994. Die Contergankatastrophe 1961 - Schock und erste Reaktionen. In Contergan - 30 Jahre danach, ed. Fritz U. Niethard, 79-84. Stuttgart: Enke.
33. Mastroianni, Anna C., Ruth Faden, and Daniel Federman. 1994. Women and health research: Ethical and legal issues of including women in clinical studies. Washington, DC: National Academy Press.
34. Matthews, Anne, Therese Dowswell, David M. Haas, Mary Doyle, and Donal P. O'Mathúna. 2010. Interventions for nausea and vomiting in early pregnancy. Cochrane Database of Systematic Reviews 2010 (9): CD007575.
35. McBride, William Griffith. 1961. Thalidomide and congenital abnormalities. Letter to the editor. The Lancet 278 (7216): 1358.
36. Meredith, Sheena. 2005. Policing pregnancy: The law and ethics of obstetric conflict. Burlington/Aldershot: Ashgate.
37. Merkatz, Ruth B., Robert Temple, Solomon Sobel, Karyn Feiden, David A. Kessler, and the Working Group on Women in Clinical Trials. 1993. Women in clinical trials of new drugs: A change in Food and Drug Administration policy. The New England Journal of Medicine 329 (4): 292-96. (Pubitemid 23203832)
38. Mohanna, Kay. 1997. Informed consent. Research in pregnancy brings special considerations. British Medical Journal (Clinical research ed.) 315 (7102): 249-50.
39. Müller-Oerlinghausen, Bruno. 2005. Die Rolle der Ärzteschaft bei der Aufklärung der Contergannebenwirkungen und die Auswirkung auf die deutsche Arzneimittelgesetzgebung. In Die Contergankatastrophe - Eine Bilanz nach 40 Jahren, ed Ludwig Zichner, Michael A. Rauschmann, and Klaus-Dieter Thomann. Darmstadt: Steinkopff Verlag.
40. Nilsson, Lennart. 1965. Ett barn blir till [A child is born]. Stockholm: Albert Bonniers förlag/Bonnier Fakta.
41. Paul-Ehrlich-Institut. 2009. Fachliche Information für Ärzte und Apotheker: Pandemie- Impfstoffe in der Schwangerschaft. http://www.pei.de/ cln-227/nn-2073016/DE/infos/fachkreise/archiv-sicherheitsinformationen/ archiv-infos-influenza-pandemie-2009-2010/schwangerschaft-04-09-2009-pandemie- impfstoffe.html (accessed1 June 2012).
42. Rodger, Marc A., Dimitri Makropoulos, Mark Walker, Erin Keely, Alan Karovitch, and Philip S. Wells. 2003. Participation of pregnant women in clinical trials: Will they participate and why? American Journal of Perinatology 20 (2): 69-76. (Pubitemid 36373503)
43. Ruof, Mary C. 2004. Vulnerability, vulnerable populations, and policy. Kennedy Institute of Ethics Journal 14 (4): 411-25.
44. Schaefer, Christof, Horst Spielmann, and Klaus Vetter. 2004. Liberalisierung nicht erforderlich. Deutsches Ärzteblatt 101 (4): A165-66.
45. Schindele, Eva. 1990. Gläserne Gebär-Mütter: Vorgeburtliche Diagnostik - Fluch oder Segen. Frankfurt am Main: Fischer Verlag.
46. Schneider, Ingrid. 1995. Föten - Der neue medizinische Rohstoff. Frankfurt am Main: Campus Verlag
47. Scott, Amy A., and Dilip M. Purohit. 1989. Neonatal renal failure: A complication of maternal antihypertensive therapy. American Journal of Obstetrics and Gynecology 160 (5): 1223-24. (Pubitemid 19144495)
48. Sherwin, Susan. 1998. Abortion through a feminist ethics lens. In Ethical Theory: Concise Anthology, Ed. Heimir Geirsson And Margaret R. Holmgren. Peterborough, Ont.: Broadview Press
49. Stormer, Nathan. 2003. Seeing the fetus: The role of technology and image in the maternal- fetal relationship. JAMA: The Journal of the American Medical Association 289: 1700.
50. Vazquez, Juan C., and Edgardo Abalos. 2011. Treatments for symptomatic urinary tract infections during pregnancy. Cochrane Database of Systematic Reviews 2011 (1): CD002256.
51. Wiesemann, Claudia. 2006. Von der Verantwortung, ein Kind zu bekommen - Eine Ethik der Elternschaft. Munich: C. H. Beck Verlag.
52. Wild, Verina. 2010. Arzneimittelforschung an schwangeren Frauen. Dilemma, Kontroversen und ethische Diskussion. Frankfurt am Main: Campus Verlag.
53. Wilson, James G. 1979. The evolution of teratological testing. Teratology 20 (2): 205-11.
54. Winkelheide, Martin. 2009. Schutz auf dem Prüfstand. Deutschlandfunk - Wissenschaft im Brennpunkt. http://www.dradio.de/dlf/sendungen/wib/1025132/ (accessed 31 May 2011).